Sofiat Akinola, Director, Health Policy and External Affairs at Roche, posted on LinkedIn:
“A step forward for more accessible cervical cancer screening.
Teal Health Care at-home HPV self-collection device, which utilizes Roche’s HPV test, represents a significant step toward more accessible cervical screening. This advancement in screening methods helps meet individuals where they are. While this represents a milestone for the US, its true potential lies in the message it signals globally: innovative solutions can help address and overcome barriers to access. As we work toward the global elimination of cervical cancer, efforts like this demonstrate how effective tools can support more equitable and scalable approaches.
I’m proud to see Roche’s technology playing a vital role in the journey to eliminate cervical cancer. Models that support equitable access bring us closer to a future where cervical cancer is no longer a public health threat.
More posts featuring Sofiat Akinola.